premieranalysis

AZRX - buy

Long
premieranalysis Updated   
NASDAQ:AZRX   None
AzurRx BioPharma Announces Completion of Enrollment in First Cohort of Phase 2b OPTION 2 Extension Study of MS1819
AZRX broke the support from 1.72 to 1.46 (61.8% fibo). If the decline continues, then buy at 1.20.


Trigger: Waiting for a momentum candle close below the gray area to buy.
Good luck!
Trade active:
time to buy !
long term target is minimum 2.60
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.